NOVACYT SHARE CAPITAL UPDATE

Novacyt_CP_Conversion OCA_31082016_ENG

Paris, France and Cambridge, UK – 31st August 2016 – Novacyt (ALTERNEXT: ALNOV), an international clinically focused diagnostics company, today announces the conversion of 15 convertible bond units from tranches five and six of the flexible bond financing agreement concluded on 31st July, 2015 with YA II PN, Ltd (formerly YA Global Master SPV Ltd), a fund managed by Yorkville Advisors LLC.